Literature DB >> 33853865

Thrombosis after covid-19 vaccination.

Paul R Hunter1.   

Abstract

Entities:  

Year:  2021        PMID： 33853865     DOI： 10.1136/bmj.n958

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.

Authors:  William N Whiteley; Samantha Ip; Jennifer A Cooper; Thomas Bolton; Spencer Keene; Venexia Walker; Rachel Denholm; Ashley Akbari; Efosa Omigie; Sam Hollings; Emanuele Di Angelantonio; Spiros Denaxas; Angela Wood; Jonathan A C Sterne; Cathie Sudlow
Journal:  PLoS Med       Date:  2022-02-22       Impact factor: 11.069

2.  National COVID-19 vaccine program progress and parents' willingness to vaccinate their children.

Authors:  Ran D Goldman; Jeffrey N Bone; Renana Gelernter; Danna Krupik; Samina Ali; Ahmed Mater; Graham C Thompson; Kenneth Yen; Mark A Griffiths; Adi Klein; Eileen J Klein; Rakesh D Mistry; Jeanine E Hall; Julie C Brown
Journal:  Hum Vaccin Immunother       Date:  2021-11-19       Impact factor: 3.452

3.  Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.

Authors:  Flavio Signorelli; Gustavo Guimarães Moreira Balbi; Nadia E Aikawa; Clovis A Silva; Léonard de Vinci Kanda Kupa; Ana C Medeiros-Ribeiro; Emily Fn Yuki; Sandra G Pasoto; Carla Gs Saad; Eduardo F Borba; Luciana Parente Costa Seguro; Tatiana Pedrosa; Vitor Antonio de Angeli Oliveira; Ana Luisa Cerqueira de Sant'Ana Costa; Carolina T Ribeiro; Roseli Eliana Beseggio Santos; Danieli Castro Oliveira Andrade; Eloisa Bonfá
Journal:  Lupus       Date:  2022-05-20       Impact factor: 2.858

4.  Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.

Authors:  Lucy L Li; Chunlei Zheng; Jennifer La; Nhan V Do; Paul A Monach; Judith M Strymish; Nathanael R Fillmore; Westyn Branch-Elliman
Journal:  Vaccine       Date:  2022-01-19       Impact factor: 3.641

5.  Why are we vaccinating children against COVID-19?

Authors:  Ronald N Kostoff; Daniela Calina; Darja Kanduc; Michael B Briggs; Panayiotis Vlachoyiannopoulos; Andrey A Svistunov; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2021-09-14

6.  Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?

Authors:  Khezar Syed; Haseeb Chaudhary; Anthony Donato
Journal:  Am J Case Rep       Date:  2021-09-03

Review 7.  Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients.

Authors:  Zeinab Mohseni Afshar; Arefeh Babazadeh; Alireza Janbakhsh; Mandana Afsharian; Kiarash Saleki; Mohammad Barary; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2021-07-01       Impact factor: 11.043

8.  New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine.

Authors:  Yasser Aladdin; Bader Shirah
Journal:  J Neuroimmunol       Date:  2021-06-07       Impact factor: 3.478

Review 9.  Evaluation of the safety profile of COVID-19 vaccines: a rapid review.

Authors:  Qianhui Wu; Matthew Z Dudley; Xinghui Chen; Xufang Bai; Kaige Dong; Tingyu Zhuang; Daniel Salmon; Hongjie Yu
Journal:  BMC Med       Date:  2021-07-28       Impact factor: 8.775

Review 10.  Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.